Our Platform
Mission Platform Scientific Materials LOWE
Pipeline
Clinical Trials
View All FAP - TUPELO Solid Tumors - ELUCIDATE Solid Tumors & Lymphoma - DAHLIA B-cell Malignancies - EXCELERIZE Solid Tumors - ENLYGHT
Partners
Investors
Investor Relations ESG Download Day Company Materials
About Us
Story Team News Press Blog
Careers

AI drug developers Recursion, Exscientia to merge

August 8, 2024

Written By:

No items found.

Read the post ›

Decoding biology to radically improve lives.®

Proud founding member of BioHive, the fastest growing life sciences community in the nation

Get In Touch

41 S Rio Grande Street
Salt Lake City, UT 84101

phone: (385) 269-0203

info@recursion.com

Get Involved

Investor Relations

Policies

Website Terms of Use

Vendor Expectations Manual & Resources

Connect

Decoding biology to radically improve lives.®

Proud founding member of BioHive, the fastest growing life sciences community in the nation

Get In Touch

41 S Rio Grande Street
Salt Lake City, UT 84101

phone: (385) 269-0203

info@recursion.com

Get Involved

Investor Relations

Policies

Website Terms of Use

Vendor Expectations Manual & Resources

Connect

© 2026 Recursion. All rights reserved.